Werner Milton H. has filed 23 insider transactions across 1 company since March 2023.
Most recent transaction: a disposition of 3643 shares of Inhibikase Therapeutics, Inc. ($IKT) on January 21, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 3643 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 3643 | $0.00 | 3,643.0000 | 23,712,220 | 9999.99% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 3643 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 3643 | $0.00 | 3,643.0000 | 23,712,220 | 9999.99% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 3643 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 3643 | $0.00 | 3,643.0000 | 23,712,220 | 9999.99% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 3643 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 3643 | $0.00 | 3,643.0000 | 23,712,220 | 9999.99% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 3643 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 3643 | $0.00 | 3,643.0000 | 23,712,220 | 9999.99% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 16667 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.07% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 16667 | $0.00 | 16,667.0000 | 23,712,220 | 9999.99% | 0.07% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 20834 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.09% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 20834 | $0.00 | 20,834.0000 | 23,712,220 | 9999.99% | 0.09% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 35000 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.15% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 23,712,220 | 9999.99% | 0.15% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.19% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 23,712,220 | 9999.99% | 0.19% |
| Jan. 3, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 5315056 | $0.00 | 5,315,056.0000 | 23,712,220 | 9999.99% | 22.42% |
| Jan. 3, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 2207671 | $0.00 | 2,207,671.0000 | 23,712,220 | 9999.99% | 9.31% |
| Jan. 3, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (Right to Buy) | 4059744 | $0.00 | 4,059,744.0000 | 23,712,220 | 9999.99% | 17.12% |
| April 1, 2024 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 6,028,210 | 9999.99% | 0.75% |
| March 1, 2023 | Inhibikase Therapeutics, Inc. | $IKT | Werner Milton H. | President and CEO | A | Stock Option (right to buy) | 210000 | $0.00 | 210,000.0000 | 0 | 9999.99% | 0.00% |